News
The data shows the prognostic value of Foresight CLARITY MRD detection at the end of frontline DLBCL in one of its largest prospective, real-world studies to date Data will be presented as an oral ...
We know if we test for minimal residual disease [MRD] using a circulating-tumor DNA test called PhasED-Seq [phased variant enrichment and detection sequencing], that if that test is positive ...
In an interview with Targeted Oncology, C. Ola Langren, MD, PhD, discussed the continuing impact of the groundbreaking FDA ODAC vote, the future of the Miami Myeloma MRD Meeting, and how researchers ...
Objective To estimate the health and financial burden of adverse childhood experiences (ACEs) in England and Wales. Design The study combined data from five randomly stratified cross-sectional ACE ...
ST. PARIS – Graham defeated Southeastern, 12-2, in non-league baseball on Thursday. For the Falcons, Brody Jenkins earned the win, Jack Traylor had 3 RBI and Breyton Reisinger, Owen Powell and Dylan ...
As for all forms of ALL, a sustained molecular MRD negativity in the bone marrow should be the primary goal of frontline treatment. The combination of TKI (targeted treatment) and blinatumomab ...
However, it has been observed that some patients in CR still relapse, likely due to minimal residual disease (MRD) that remains below the detection limit of standard clinical, imaging, and pathology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results